alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

Term ID

CHEBI:61579

Synonyms

(Gal)1 (GalNAc)1 (Neu5Ac)1
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulonosyl-(2->3)-beta-D-galactosyl-(1->3)-2-acetamido-2-deoxy-D-galactose
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-D-GalNAc
Neu5Acalpha(2-3)Galbeta(1-3)GalNAc

Definition

A linear amino trisaccharide comprising an α-N-acetylneuraminyl residue (2→3)-linked to a β-D-galactosyl residue, which is in turn linked (1→3) to N-acetyl-D-galactosamine.

References

glygen:G56299XO
glytoucan:G56299XO
kegg.glycan:G00261
pubmed:11294842
pubmed:11459848
pubmed:12015815
pubmed:12950230
pubmed:19443021
pubmed:2055602
pubmed:3242812
pubmed:3371361
pubmed:3801456
pubmed:7737204
pubmed:7757427
pubmed:9405387
reaxys:7247033

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype affecting alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-D-GalpNAc

Human Disease Model